Skip to content
The Nexus
DossierENTITY

Waldo Swiegers

Coverage of Waldo Swiegers in the Nexus archive.

Earliest in view: May 4 · 10:45 UTCMost recent: May 26 · 05:15 UTC
Co-mentioned in this coverage
Bloombergorganization2Sasol Ltd.organization1Johannesburgplace1Analyststopic1Stock Rallytopic1Skepticismtopic1Immune System Biotech Odysseyorganization1USplace1
Recent coverage
  • BUSINESSMay 26 · 05:15 UTCBLOOMBERG
    Sasol’s Blistering Rally Meets Growing Skepticism From Analysts

    Sasol Ltd. has experienced a significant stock price increase, but analysts are increasingly skeptical about its sustainability. The company's headquarters in Johannesburg are highlighted in the article, with Bloomberg providing the photograph.

  • BUSINESSMay 4 · 10:45 UTCBLOOMBERG
    Immune System Biotech Odyssey Seeks $238.3 Million in US IPO

    Immune System Biotech Odyssey is seeking $238.3 million in a US initial public offering. The company is involved in biotechnology related to the immune system. This IPO is a significant step for the company's growth and development.